Screening tool for HIV and hepatitis C
Part of Immune system & allergy, Infections clinical trials.
This study is testing a tool to find people who may be at risk for or already have HIV or hepatitis C. It aims to connect them with care and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 65 years old.
- You live in the health area where the study is taking place or are referred by a health worker.
- You agree to take part in the study and sign a consent form.
- You have not already been enrolled in this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to help primary care doctors offer routine HIV and hepatitis screening to their adult patients. It may make it easier to catch these infections early.
This trial is for people who use drugs and have hepatitis C. It tests an approach to help treat and manage hepatitis C in a supportive way.
This study evaluates a new blood test that checks for HIV, hepatitis B, hepatitis C, and syphilis all at once. It is designed to see how well the test works in different groups of people, including those with known infections and those without.
This study tests a new tool that helps doctors in the emergency department quickly check if a patient needs testing for hepatitis C. The goal is to find more cases early and connect people to care.
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
Hear when a new HIV/AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.